Related Experiment Video
Updated: Mar 16, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
Radiogenomics: towards a personalized radiation oncology
John D Roberson1, Omer L Burnett, Nathaniel Robin
1aDepartment of Medicine bDepartment of Radiation Oncology cDepartment of Genetics, University of Alabama School of Medicine, Birmingham, Alabama, USA.
Radiogenomics research explores genetic factors influencing radiation sensitivity in cancer patients. Advances in genomics are identifying genes to predict and manage long-term side effects, improving patient care.
Area of Science:
- Genomics
- Radiation Biology
- Radiogenomics
Background:
- Pediatric cancer survivors treated with radiation face risks of long-term side effects like cardiac disease and secondary malignancies.
- Genetics significantly influences individual susceptibility to radiation-induced side effects, establishing the field of radiogenomics.
- Early candidate gene studies yielded limited results, but recent genome-wide association studies are identifying key genes.
Purpose of the Study:
- To evaluate the field of radiogenomics in the context of recent advancements in genomics and radiation biology.
Main Methods:
- Review of recent developments in genomics and radiation biology.
- Analysis of genome-wide association studies (GWAS) for radiosensitivity.
- Evaluation of candidate gene studies.
Main Results:
- Genome-wide association studies are beginning to identify genetic variants associated with radiosensitivity.
- Genomic technologies are becoming more accessible and cost-effective, facilitating broader research.
- Understanding genetic factors is crucial for predicting patient susceptibility to radiation side effects.
Conclusions:
- Radiogenomics is an evolving field crucial for understanding individual radiosensitivity.
- Continued progress in genomic technologies will enhance the identification of genes influencing radiation response.
- Improved understanding of radiogenomics will lead to better patient counseling regarding adverse effects.
More Related Videos
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
06:20Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
Published on: March 11, 2021
Related Concept Videos
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacogenetics and Pharmacogenomics: Overview
Targeted Cancer Therapies
Targeted Cancer Therapies
There are several types of targeted therapies against...